Perbio Science
Advanced search
Log in
Press Room
Releases
Multimedia
About
Extraordinary General Meeting of Perbio Science AB
9/24/2003 11:53 AM EST
EXTRAORDINARY GENERAL MEETING OF PERBIO SCIENCE AB
At today's it was
decided that the Board shall consist of four Board Members, and to elect
Paul M. Meister, Todd M. DuChene, Jacob Melander and Carl-Johan Deuschl
as new members of the Board. Furthermore, it was decided that no
remuneration shall be paid to the Board Members. At the subsequent
statutory board meeting, Paul M. Meister was elected as Chairman of the
Board.
As previously announced the last day of trading for the shares in Perbio
Science at the Stockholm Stock Exchange is on 24 September 2003 and
consequently the delisting of the share will occur on 25 September 2003.
FURTHER INFORMATION
Annika Hultkrantz phone: +46 42 26 90 96
Notice
9/15/2003 3:54 AM EST
NOTICE
FSII Sweden Holdings AB, reg. no. 556643-8072, ("Fisher") owns
approximately 93.6 % of all shares in Perbio Science AB (publ), reg. no.
556567-0626,...
Application for delisting of the shares
9/10/2003 12:47 PM EST
PRESS RELEASE, 10 September 2003
·
· Redemption of minority shares initiated
FSII Sweden Holdings AB ("Fisher Sweden"), which owns 93.6 per cent of
Notice
9/10/2003 4:40 AM EST
NOTICE OF EXTRAORDINARY GENERAL MEETING
The Shareholders of Perbio Science AB (publ) are hereby invited to
attend an Extraordinary General Meeting to be held on...
Improved cash offer from Fisher
8/20/2003 3:52 AM EST
Fisher Scientific International Inc. (Fisher), has today announced an
increase in its recommended cash offer announced on 26 June 2003 to the
shareholders and holders of...
Invitation to participate in conference call on Thursday August 7
8/4/2003 11:25 AM EST
Invitation to participate in additional conference call
regarding Perbio Science AB's Interim Report January - June 2003
The presentation and Q&A session regarding...
Perbio Science AB Interim Report January - June 2003
8/1/2003 4:56 AM EST
Perbio Science AB Interim Report January-June 2003
Healthy sales growth impacted by weak US dollar
· Net sales were SEK 1,033 (1,108) million which, as a...
Interim Report Perbio Science AB January - June 2003
8/1/2003 4:50 AM EST
Healthy sales growth impacted by weak US dollar
· Net sales were SEK 1,033 (1,108) million which, as a result of
the weak US dollar, was a decline of 7 percent....
Perbio recommends cash offer from Fisher
6/26/2003 4:05 AM EST
Fisher Scientific International Inc. ("Fisher"), a world leading
supplier of products and services to science, has today announced a
public cash offer ("the Offer") to...
Perbio Science AB Interim Report January - March 2003
4/28/2003 5:09 AM EST
Perbio Science AB Interim Report January-March 2003
Continued healthy sales growth although impacted by weak dollar
· Net sales first quarter were SEK 518 (552)...
Interim Report Perbio Science AB January - March 2003
4/28/2003 5:07 AM EST
Interim report Perbio Science AB January - March 2003
Continued healthy sales growth although impacted by weak dollar
· Net sales first quarter were SEK 518 (552)...
Annual General Meeting of Perbio Science AB
4/11/2003 4:32 AM EST
ANNUAL GENERAL MEETING OF PERBIO SCIENCE AB
· Caroline Sundewall and CEO Leland G. Foster new members of the
Board
· Authorisation for the Board to decide...
EU Approves Test for BSE (Mad Cow Disease)
3/14/2003 8:14 AM EST
Perbio Science AB today announced the expected approval from the EC
Scientific Steering Committee of the Prionics LIA Test Kit for BSE (Mad
Cow Disease).
"We...
Notice of Annual General Meeting on 10 April 2003
3/10/2003 2:34 AM EST
NOTICE OF ANNUAL GENERAL MEETING
The Shareholders of Perbio Science AB (publ) are hereby invited to
attend the Annual General Meeting to be held on Thursday, 10th...
Perbio Science year-end report 2002
2/11/2003 4:30 AM EST
Good growth and high profitability despite weaker USD
· Net sales up 15 percent to SEK 2 175 (1 899) million
· Operating income before amortization of goodwill up...
Year-end report 2002 Perbio Science AB
2/11/2003 4:22 AM EST
Year-end report Perbio Science AB 2002
Good growth and high profitability despite weaker USD
· Net sales up 15 percent to SEK 2,175 (1,899) million
·...
Perbio Science's subsidiary Atos Medical AB has acquired the business operations of Therabite Corp
12/19/2002 3:05 AM EST
Perbio Science's subsidiary Atos Medical AB has acquired the business
operations of Therabite Corp.
Perbio Science's subsidiary Atos Medical AB has acquired the...
Perbio Science AB Interim report January - September 2002
10/23/2002 3:53 AM EST
Perbio Science AB
Interim report
January-September 2002
Continued growth despite weaker US dollar
· Net sales up 19 % to SEK 1,663 (1,396)...
Perbio Science AB Interim report January - September 2002
10/23/2002 3:41 AM EST
Perbio Science AB
Interim report
January-September 2002
Continued growth despite weaker US dollar
· Net sales up 19 % to SEK 1,663 (1,396)...
Mats Fischier to become Chairman, new CEO appointed
9/26/2002 3:02 AM EST
The Board of Perbio Science AB ("Perbio" or the Company) decided today
to elect CEO Mats Fischier to be Chairman of the Board and to appoint
Leland G. Foster, the...
Perbio companies at the top of the growth table
9/10/2002 8:46 AM EST
The Perbio Science AB subsidiary company Atos Medical's growth has been
rapid and persistent and has resulted in a place on this year's Marathon
List.
Atos...
SEE ALL NEWS
Perbio Science
RSS
Subscribe by Email
View more
Tweet
Media
more